Legal Representation
Attorney
Monte L. Falcoff
USPTO Deadlines 2 active 2 overdue
| Deadline Type | Event Code | Deadline Date | Days Until | Priority | Extension Available |
|---|---|---|---|---|---|
|
OFFICE ACTION
Non-Final Action Mailed |
CNRT | Feb 13, 2025 | 144 days overdue | Critical | Until May 13, 2025 |
|
OFFICE ACTION
Non-Final Action E-Mailed |
GNRT | Feb 13, 2025 | 144 days overdue | Critical | Until May 13, 2025 |
Application History
9 events| Date | Code | Type | Description |
|---|---|---|---|
| Mar 3, 2025 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Mar 3, 2025 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Nov 13, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Nov 13, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Nov 13, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Nov 8, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
| Oct 17, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jul 11, 2024 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Apr 25, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Diagnostic kits and instruments primarily comprised of antibodies and medical diagnostic reagents for testing kidney diseases, prediabetes, diabetes, hypertension, dementia, neurological diseases, aging, cardiovascular diseases, gastrointestinal diseases for medical use; testing apparatus being diagnostic kits for medical purposes primarily comprised of reagents for creating assays to capture and detect disease biomarkers, namely, for detecting kidney diseases.
Class 010
Diagnostic kits and instruments primarily comprised of a coated surface, a reagent, and an immunoassay using antibodies or molecular probes for kidney diseases, prediabetes, diabetes, hypertension, dementia, neurological diseases, aging, cardiovascular diseases, gastrointestinal diseases and medical use; testing apparatus and instruments for medical purposes in the nature of a coated surface, a reagent, and an immunoassay using antibodies or molecular probes used to create assays to capture and detect disease biomarkers, namely, for detecting kidney diseases.
Class 044
Medical diagnostic services relating to prediabetes, diabetes, kidney disease, and hypertension; medical testing services relating to the diagnosis and treatment of disease; medical services, namely, administering reagent-based tests for others for diagnosis of diseases; providing medical diagnostic information services for determining medical risk-scores for prediabetes, diabetes, kidney disease, and hypertension using computers, software and algorithms.
Classification
International Classes
005
010
044